Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial

NCT06670963 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Anemia
Sepsis
Septic Shock

Interventions

DRUG: Iron
DRUG: EPO
DRUG: 0.9 % NaCl

Sponsor

Piotr Czempik